Capricor Therapeutics | CAPR - Ordinary Share Capital


Capricor Therapeutics reported $57.37M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Bioline Rx USD 2.61B 53.2M Sep/2025
Capricor Therapeutics USD 57.37M 11.65M Dec/2025
Cipla INR 807.78M 17K Mar/2026
Cytokinetics USD 124.43M 2.17M Mar/2026
Geron USD 640.9M 2.54M Mar/2026
Grifols EUR 680.58M 846.11K Dec/2025
Immunic USD 120.38M 21.73M Dec/2025
J&J USD 2.41B 1.74M Dec/2025
Plus Therapeutics USD 138.68M 7.07M Dec/2025
Prothena USD 53.83M 3K Dec/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Sarepta Therapeutics USD 105.57M 607K Mar/2026